Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Kaletra in Combination With Antiretroviral Agents (PROTEKT)

This study has been completed.
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) ) Identifier:
First received: February 24, 2010
Last updated: February 4, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)